Related Experiment Video
Updated: Aug 11, 2026

Thermal Imaging to Study Stress Non-invasively in Unrestrained Birds
Published on: November 6, 2015
Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications
1INSERM Unit 259: Laboratoire de Psychobiologie des Comportements Adaptatifs, Université de Bordeaux II., France. pier-vincenzo.piazza@bordeaux.inserm.fr
Abstract:
The observations presented in this review suggest that glucocorticoids are one of the biological substrates of reward. These hormones are secreted in response to rewarding stimuli, such as food, a receptive sexual partner or drugs of abuse. Furthermore, manipulations of the secretion of glucocorticoids modify reward-related behaviours, and administration of these hormones, in the range of physiological stress levels, has positive reinforcing effects. The rewarding effects of glucocorticoids are probably mediated by a glucocorticoid-induced stimulation of the mesencephalic dopaminergic transmission, one of the principal neural substrates of reward. It is proposed that the rewarding effects of glucocorticoids play the role of counteracting the aversive effects of external aggressions, allowing a better coping with threatening situations. However, a sustained increase in the secretion of these hormones, or an hypersensitivity to their rewarding effects, could determine reward-related pathologies, such as a predisposed state to develop drug-abuse. In conclusion, through their reward-related effects, glucocorticoids may play a key role in tuning adaptation to stress and in determining reward-related behavioral pathologies.
Related Concept Videos
Hypothalamic-Pituitary Axis
Regulation of Metabolism
Hormones of the Adrenal Glands
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Cushing Syndrome I: Introduction
Cushing Syndrome II: Pathophysiology

